Brief: Spago Nanomedical Q4 Sales SEK 731 Thousand
Feb 07 (Reuters) - Spago Nanomedical Q4 adjusted EPS SEK -0.08. * Q4 operating expenses SEK -12.06 million * Q4 net income SEK -9.417 million
Feb 07 (Reuters) - Spago Nanomedical Q4 adjusted EPS SEK -0.08. * Q4 operating expenses SEK -12.06 million * Q4 net income SEK -9.417 million